Objective: Uric acid is becoming more and more important in the physiopathology of arterial hypertension, and is considered an independent risk factor of cardiovascular morbidity and mortality.
Aim:
To study whether ansiolitic therapy leads to a better control of blood pressure (BP). Patients and methods: Two groups of 25 hypertensive women (50 to 65 year-old) each were randomly selected. No drugs were administered 4 weeks before treatment. The patients of group I were treated with enalapril 20 mg/day; those of group II received enalapril 20 mg/day and bromazepan 3 mg/day. BP was measured at onset and after 12 weeks of treatment. Statistical analysis: Student's t test was used for paired samples. BP was measured using a mercury sphygmomanometer. Patients did not show other associated pathologies. Results: The two groups showed successful results in the control of BP (systolic and diastolic). However, no significant differences were found bewteen the groups, which could suggest that one treatment was more effective than the other.
Conclusions:
Ansiolitic drugs do not increase the effects of antihypertensive drugs; ansiolitic drugs act on anxiety symptomatology, improving patient's condition, but it does not result in a higher decrease in BP. Objectives: To assess the changes in the lipid profile of menopausal women and its behavior depending on whether they are normotensive or hypertensive. Patients and Methods: From 217 menopausal women without other associated pathologies, 65 were selected, with ages between 40 and 55 years and a mean duration of menopause of 2.20 Ϯ 2.60 years, and divided into four groups: 2 groups of normotensive and 2 groups of hypertensive. The following protocol was applied: complete clinical history, laboratory tests (after 15 days without drug therapy). A group of 18 normotensive women were radomly treated with transdermic hormone replacement therapy (HRT) (17␤-estradiol 50g/l patch every 4 consecutive days ϩ natural progesterone 200 mg from days 12 to 25 of each month), the other 16 normotensive women with no treatment. 15 hypertensive women were treated with captopril (50 -100 mg/day) and HRT, and the other 15 with captopril alone. Results:
